Table 2.

Primary and secondary outcomes of the 12-week randomized study: S&P versus AID

	Run-in		12-Week study		AID effect Mean (95% CI)
Outcome	S&P (n = 22)	AID (n = 49)	S&P (n = 22)	AID (n = 49)		P value
Primary outcome: SG reading <70 mg/dL (%time)	10.3 ± 5.5	9.4 ± 4.2	6.8 ± 3.5	2.8 ± 1.4	−3.7 (−4.8, −2.6)	<0.001
Secondary outcomes, SG reading, mg/dL (%time)*
70–180	61.5 ± 15.6	61.2 ± 11.9	64.2 ± 13.3	74.4 ± 8.9	+8.6 (5.2, 12.1)	<0.001
>180	28.1 ± 15.8	29.3 ± 13.3	28.9 ± 13.6	22.8 ± 8.9	−5.3 (−8.7, −1.8)	0.004
Mean	148.3 ± 26.0	150.7 ± 23.3	151.9 ± 22.7	147.9 ± 12.9	−2.9 (−8.9, 3.1)	0.342
<54	3.3 ± 2.8	3.1 ± 2.1	1.5 ± 1.2	0.6 ± 0.5	−0.8 (−1.2, −0.5)	Not tested

Data are reported as mean ± SD unless otherwise indicated.

^*Hierarchical analysis.